Todos Med Ltd (TOMDF)

[Randylus]

Dilution is not a major concern with previously announced convertible note extension agreements and lock-up agreements. Company is planning to up list to Nasdaq CM and the 1-10 (up to) 1-100 RS will enable this.

It still has to be voted for and enacted with shareholder approval. Voting shareholders will do what's best for the company. It's possible Todos Medical would not survive going forward without this action so, you have to choose the lesser of the two evils. IMHO

https://investor.todosmedical.com/news-events/press-releases/detail/38/todos-medical-announces-legacy-convertible-note-extension

REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced it has entered into convertible note extension agreements and lock-up agreements with certain institutional investors who participated in the Company’s previously announced $1.35M financing round in Q1 2019 (the ‘2019 Bridge Financing’). All remaining investors who participated in the 2019 Bridge Financing have agreed to extend the maturity of those notes until mid-August 2020 and have entered into lock-up agreements with the Company that preclude them from selling common shares in the market until mid-August 2020